MedPath

Comparison of Nasal CPAP and Nasal SIMV in Transient Tachypnea of Newborn

Phase 4
Conditions
Transient Tachypnea of Newborn
Interventions
Device: Nasal SIMV
Device: nasal CPAP
Registration Number
NCT01499238
Lead Sponsor
Zekai Tahir Burak Women's Health Research and Education Hospital
Brief Summary

The investigators aimed to compare the efficacy of nasal SIMV and nasal CPAP in patients with wet lung.

Detailed Description

We aimed to compare two types of ventilatory support in cases of transient tachypnea of newborn who are \>35 gestational week.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria
  • >35 gestational week
  • wetlung
Exclusion Criteria
  • major congenital anomalies

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
nasal SIMVNasal SIMVrate: 30-50/min, PIP: 16, PEEP: 4-6, fİO2: 40%
nasal CPAPnasal CPAPPEEP: 4-6 mmHg, Fio2: 40%
Primary Outcome Measures
NameTimeMethod
efficacy of nasal SIMV and nasal CPAP in infants with wet lung who are >35 weeks gestational age3 months
Secondary Outcome Measures
NameTimeMethod
Complications of respiratory support, respiratory insufficiency3 months

pneumothorax

Trial Locations

Locations (2)

Zekai Tahir Burak Maternity Teaching Hospital, Division of Neonatology

🇹🇷

Ankara, Turkey

Zekai Tahir Burak Maternity Teaching Hospital

🇹🇷

Ankara, Turkey

© Copyright 2025. All Rights Reserved by MedPath